Home » Topics » Regulatory » Patents

Patents
RSS

Hinova Pharmaceuticals discovers URAT1 inhibitors

June 26, 2017

Roche identifies cannabinoid CB2 receptor agonists

June 26, 2017

Naeja-Rgm Pharmaceuticals patents cephem derivatives

June 26, 2017

Gan & Lee Pharmaceuticals divulges CDK4 and CDK6 inhibitors

June 26, 2017

Merck & Co. discloses leukotriene BLT1 receptor antagonists

June 26, 2017

GlaxoSmithKline presents novel UDP-3-O-acyl-GlcNAc deacetylase inhibitors

June 23, 2017

AstraZeneca/Cancer Research Technology patent GLS inhibitors

June 23, 2017

Merck & Co. divulges coagulation factor XIa/kallikrein B inhibitors

June 23, 2017

Merck & Co. patents novel beta-secretase 1/2 inhibitors

June 22, 2017

CSIR identifies new CDK2/cyclin A and CDK9/cyclin-T1 inhibitors

June 22, 2017

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...